Skip to main content
SpringerLink
Log in
Book cover

Color Atlas of Melanocytic Lesions of the Skin pp 237–259Cite as

Melanoma of the Trunk and Limbs Including Superficial and Nodular Melanoma

  • Chapter

  • 2118 Accesses

Abstract

Superficial and nodular melanoma of the trunk and limbs are the most frequent melanoma subtypes in Caucasians, and are largely responsible for the increased incidence of melanoma noted over the past few decades [1, 2]. Superficial spreading melanoma (SSM) is defined as an invasive melanoma that has an in-situ component beyond three rete ridges of its invasive component at the dermal layer. The radial growth phase of SSM is characterized by invasion of tumor cells both singly and in nests upward within the epidermis (pagetoid spread). In the natural progression of the neoplasm the melanoma will progress from the radial growth phase to the vertical growth phase. The SSM may arise in a preexisting nevus or de novo, and although a predilection for the trunk (the back of men) and limbs in women is documented, SSM can certainly develop at any site on the body [3, 4].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664–1678

    Article  PubMed  CAS  Google Scholar 

  • Balch CM, Houghton AN, Sober AJ, Soong SJ. Cutaneous melanoma. Quality Medical Publishing, St. Louis, 2003

    Google Scholar 

  • Clark WH Jr. A classification of malignant melanoma in man correlated wth histogenesis and biological behaviour. In: Montagna W, Hu F (eds) Advances in the biology of the skin, vol. VIII. New York: Pergamon, 1967, p. 621

    Google Scholar 

  • Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705–727

    PubMed  Google Scholar 

  • Poetsch M, Dittberner T, Woenckhaus C. Can different genetic changes characterize histogenetic subtypes and biologic behavior in sporadic malignant melanoma of the skin? Cell Mol Life Sci 2003;60:1923–1932

    Article  PubMed  CAS  Google Scholar 

  • Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135–2147

    Article  PubMed  CAS  Google Scholar 

  • Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis, I: the role of patients. Int J Cancer 2000;89:271–279

    Article  PubMed  CAS  Google Scholar 

  • Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma. CA Cancer J Clin 1985;35:130–151

    Article  PubMed  CAS  Google Scholar 

  • Thomas L, Tranchand P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology 1998;197:11–17

    Article  PubMed  CAS  Google Scholar 

  • Del Mar CB, Green AC. Aid to diagnosis of melanoma in primary medical care. Br Med J 1995;310:492–495

    CAS  Google Scholar 

  • Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RA. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 1994;130:48–50

    Article  PubMed  CAS  Google Scholar 

  • Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis, II: the role of doctors. Int J Cancer 2000;89:280–285

    Article  PubMed  CAS  Google Scholar 

  • Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol 2001;44:979–986

    Article  PubMed  CAS  Google Scholar 

  • Pizzichetta MA, Talamini R, Stanganelli I, Puddu P, Bono R, Argenziano G, Veronesi A, Trevisan G, Rabinovitz H, Soyer HP. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol 2004;150:1117–1124

    Article  PubMed  CAS  Google Scholar 

  • Kelly JW, Chamberlain AJ, Staples MP, McAvoy B. Nodular melanoma. No longer as simple as ABC. Aust Fam Phys 2003; 32:706–709

    Google Scholar 

  • Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol 2003;48:694–701

    Article  PubMed  Google Scholar 

  • Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions. Results of a Consensus Meeting via Internet. J Am Acad Dermatol 2003;48:679–693

    Article  PubMed  Google Scholar 

  • Soyer HP, Argenziano G, Talamini R, Chimenti S. Is dermoscopy useful for the diagnosis of melanoma? Arch Dermatol 2001;137:1361–1363

    PubMed  CAS  Google Scholar 

  • Bafounta M, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of the diagnostic tests. Arch Dermatol 2001;137:1343–1350

    PubMed  CAS  Google Scholar 

  • Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002;3:159–165

    Article  PubMed  CAS  Google Scholar 

  • Yadav S, Vossaert KA, Kopf AW, Silverman M, Grin-Jorgensen C. Histologic correlates of structures seen on dermoscopy (epiluminescence microscopy). Am J Dermatopathol 1993;15:297–305

    Article  PubMed  CAS  Google Scholar 

  • Soyer HP, Kenet R.O, Wolf IH, Kenet BJ, Cerroni L. Clinicopathological correlation of pigmented skin lesions using dermoscopy. Eur J Dermatol 2000;10:22–28

    Article  PubMed  CAS  Google Scholar 

  • Soyer HP, Smolle J, Hödl S, Pachernegg H, Kerl H. Surface microscopy: a new approach to the diagnosis of cutaneous pigmented tumors. Am J Dermatopathol 1989;11:1–10

    Article  PubMed  CAS  Google Scholar 

  • Soyer HP, Massone C, Ferrara G, Argenziano G. Limitations of histopathologic analysis in the recognition of melanoma: a plea for a combined diagnostic approach of histopathologic and dermoscopic evaluation. Arch Dermatol 2005;141:209–211

    Article  PubMed  Google Scholar 

  • Bauer J, Metzler G, Rassner G, et al. Dermatoscopy turns histopathologist's attention to the suspicious area in melanocytic lesions. Arch Dermatol 2001;137:1338–1340

    PubMed  CAS  Google Scholar 

  • Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analyses of pigmented skin lesions. J Am Acad Dermatol 1987;17:571–583

    PubMed  CAS  Google Scholar 

  • Kenet RO, Kang S, Kenet B, et al. Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol 1993;129;157–174

    Google Scholar 

  • Stolz W, Riemann A, Cognetta AB, et al. ABCD rule of dermoscopy: a new practical method for early recognition of malignant melanoma. Eur J Dermatol 1994;4:521–527

    Google Scholar 

  • Kittler H, Seltenheim M, Dawid M et al. Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy. J Am Acad Dermatol 1999;40:558–562

    Article  PubMed  CAS  Google Scholar 

  • Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55–62

    Article  PubMed  CAS  Google Scholar 

  • Argenziano G, Fabbrocini G, Carli P, Giorgi V de, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998;134:1563–1570

    Article  PubMed  CAS  Google Scholar 

  • Blum A, Rassner G, Garbe C. Modified ABC-point list of dermoscopy: a simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions. J Am Acad Dermatol 2003;48:672–678

    Article  PubMed  Google Scholar 

  • Ferrara G, Argenziano G, Soyer HP, Chimenti S, Blasi A di, Pellacani G, Peris K, Piccolo D, Rubegni P, Seidenari S, Staibano S, Zalaudek I, Rosa G. Spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol. 2005;141:1381–1387

    Article  PubMed  Google Scholar 

  • Marghoob AA, Braun PR, Kopf AW (eds) Atlas of dermoscopy. London: Taylor and Francis, 2005

    Google Scholar 

  • Steiner A, Pehamberger H, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J Am Acad Dermatol. 1987;17:584–591

    Article  PubMed  CAS  Google Scholar 

  • Argenziano G, Zalaudek I, Corona R, Sera F, Cicale L, Petrillo G, Ruocco E, Hofmann-Wellenhof R, Soyer HP. Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol 2004;140:1485–1489

    Article  PubMed  Google Scholar 

  • Kreusch JF. Vascular patterns in skin tumors. Clin Dermatol 2002;20:248–25

    Article  PubMed  Google Scholar 

  • Giorgi V de, Carli P. Dermoscopy and preoperative evaluation of melanoma thickness. Clin Dermatol 2002;20:305–308

    Article  Google Scholar 

  • Argenziano G, Fabbrocini G, Carli P, Giorgi V de, Delfino M. Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness. J Am Acad Dermatol 1999;40:61–68

    Article  PubMed  CAS  Google Scholar 

  • Pellacani G, Seidenari S. Preoperative melanoma thickness determination by 20-MHz sonography and digital videomicroscopy in combination. Arch Dermatol 2003;139:293–298

    Article  PubMed  Google Scholar 

  • Matz H, Orion E, Ruocco V, Wolf R. Clinical simulators of melanoma. Clin Dermatol 2002;20:212–221

    Article  PubMed  Google Scholar 

  • Cerroni L, Kerl H. Simulators of malignant melanoma of the skin. Eur J Dermatol 1998;8:388–396

    PubMed  CAS  Google Scholar 

  • Zalaudek I, Ferrara G, Stefani A di, Argenziano G. Dermoscopy for challenging melanoma; how to raise the “red flag” when melanoma clinically looks benign. Br J Dermatol 2005;153:200–2002

    Article  PubMed  CAS  Google Scholar 

  • Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000;136:1012–1016

    Article  PubMed  CAS  Google Scholar 

  • Malvehy J, Puig S, Marti-Laborda RM. Dermoscopy of skin lesions in two patients with xeroderma pigmentosum. Br J Dermatol 2005;152:271–278

    Article  PubMed  CAS  Google Scholar 

  • Ragi G, Turner MS, Klein LE, Stoll HL Jr. Pigmented Bowen's disease and review of 420 Bowen's disease lesions. J Dermatol Surg Oncol 1988;14:765–769

    PubMed  CAS  Google Scholar 

  • Zalaudek I, Argenziano G. Glomerular vessels in Bowen's disease. Br J Dermatol 2004;151:720

    Article  PubMed  CAS  Google Scholar 

  • Izikson L, Sober AJ, Mihm MC Jr, Zembowicz A. Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol 2002;138:1562–1566

    Article  PubMed  Google Scholar 

  • Argenziano G, Rossiello L, Scalvenzi M, Staibano S, Ruocco E, Cicale L, Soyer HP. Melanoma simulating seborrheic keratosis: a major dermoscopy pitfall. Arch Dermatol 2003;139:389–391

    Article  PubMed  Google Scholar 

  • Braun RP, Rabinovitz HS, Krischer J, Kreusch J, Oliviero M, Naldi L, Kopf AW, Saurat JH. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol 2002;138:1556–1560

    Article  PubMed  Google Scholar 

  • Giorgi V de, Massi D, Stante M, Carli P. False “melanocytic” parameters shown by pigmented seborrheic keratoses: a finding which is not uncommon in dermoscopy. Dermatol Surg 2002;28:776–779

    Article  Google Scholar 

  • Zaballos P, Puig S, Malvehy J. Dermoscopy of atypical dermatofibroma: central white network.Arch Dermatol 2006;142:126

    Article  PubMed  Google Scholar 

  • Ferrari A, Soyer HP, Peris K, et al. Central white scar-like patch: a dermatoscopic clue for the diagnosis of dermatofibroma. J Am Acad Dermatol 2000;43:1123–1125

    Article  PubMed  CAS  Google Scholar 

  • Blum A, Metzler G, Bauer J, Rassner G, Garbe C. The dermoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology 2001;203:50–52

    Article  PubMed  CAS  Google Scholar 

  • Bugatti L, Filosa G, Broganelli P, Tomasini C. Psoriasis-like dermoscopic pattern of clear-cell acanthoma. J Eur Acad Dermatol Venerol 2003;17:452–455

    Article  Google Scholar 

  • Zalaudek I, Hofmann-Wellenhof R, Argenziano G. Dermoscopy of clear-cell acanthoma differs from dermoscopy of psoriasis. Dermatology 2003;207:428

    Article  PubMed  Google Scholar 

  • Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995;21:669–683

    Article  PubMed  CAS  Google Scholar 

  • Ding JA, Hashimoto H, Sugimoto T, et al. Bednar tumor (pigmented dermatofibrosarcoma protuberans): an analysis of six cases. Asta Pathol Jpn 1990;40:744–754

    CAS  Google Scholar 

  • Fretzin DF, Helwig EB. Atypical fibrous xantoma: a clinicopathological study of 140 cases. Cancer 1973;31:1541–1552

    Article  PubMed  CAS  Google Scholar 

  • Saitoh K, Saga K, Okazaki M, et al. Pigmented primary carcinoma of the breast: a clinical mimic of malignant melanoma. Br J Dermatol 1998;125:536–539

    Google Scholar 

  • Fernandez-Figueras MT, Puig L, Casanova JM, et al. Pigmented epidermotropic ductal carcinoma of the breast in a male. J Cutan Pathol 1995;22:276–280

    Article  PubMed  CAS  Google Scholar 

  • Perez IR, Fenske NA, Brozana SJ. Malignant melanoma differential diagnosis of the pigmented lesion. Semin Surg Oncol 1993;9:168–173

    PubMed  CAS  Google Scholar 

  • Zaballos P, Llambrich A, Puig S, Malvehy J. Dermoscopy of solitary angiokeratoma. Arch Dermatol 2007 (in press)

    Google Scholar 

  • Clark WH Jr, From L, Bernardine EA, Mihm MC. The histogenesis and biologic behaviour of primary human malighnant melanomas of the skin. Cancer Res 1969; 29:705

    PubMed  Google Scholar 

  • Guerry D IV, Synnestvedt M, Elder DE, Schultz D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. Invest Dermatol 1993;100:342S

    Article  Google Scholar 

  • Taran JM, Heenan PJ. Clinical and histologial features of level 2 cutaneous malignant melanoma associated with metastasis. Cancer 2001;91:1822

    Article  PubMed  CAS  Google Scholar 

  • Ronan SG, Eng AM, Briele HA, et al. Thin melanoma with regression and metastasis. Arch Dermatol 1978;114:732

    Article  Google Scholar 

  • Megahed M, Schon M, Selimovic D, Schon MP. Reliability of diagnosis of melanoma in situ. Lancet 2002;359(9321):1921–1922

    Article  PubMed  Google Scholar 

  • Abramova L, Slingluff CL Jr, Patterson JW. Problems in the interpretation of apparent “radial growth phase” malignant melanomas that metastasize. J Cutan Pathol 2002;29:407–414

    Article  PubMed  Google Scholar 

  • Clark WH Jr, Elder DE, Van Horn M. The biologic forms of malignant melanoma. Hum Pathol 1986;5:443

    Article  Google Scholar 

  • Elder D, Elenitsas R, Jaworsky C, Johnson Jr. B. Lever's histopathology of the skin, 8th edn, 1997

    Google Scholar 

  • Tsao H, Sober A. Acquired precursor lesions and markers of increased risk for cutanous melanoma. In: Balch C, Houghton A, Sober A, Soong S (eds) Cutaneous melanoma, 4th edn. Quality Medical Publishing, St. Louis, 2003:121–134

    Google Scholar 

  • Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignantmelanoma in melanoma prone families with dysplastic nevi. Ann Intern Med 1985;102:458–465

    PubMed  CAS  Google Scholar 

  • Kraemer KH, Tucker M, Tarone R, Elder DE, Clark WH Jr. Rise of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med 1986;315:1615–1616

    Article  PubMed  CAS  Google Scholar 

  • Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDNK2A mutations ifor melanoma. J Natl Cancer Inst 2002;94:894–965

    PubMed  CAS  Google Scholar 

  • Tsao H, Sober AJ. Ultraviolet radiation and malignant melanoma. Clin Dermatol 1998;16:67–73

    Article  PubMed  CAS  Google Scholar 

  • Kang S, Barnhill RL, Mihm MC Jr, Sober AJ. Multiple primary malignant melanomas. Cancer 1992;70:1911–1916

    Article  PubMed  CAS  Google Scholar 

  • Goggins WB, Tsao H. A population based analyses of risk factors for a second primary cutanous melanoma among melanoma survivors. Cancer 2003;97:639–643

    Article  PubMed  Google Scholar 

  • Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004;2;351:998–1012

    Google Scholar 

  • Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635–3648

    PubMed  CAS  Google Scholar 

  • Ross MI, Balch C, Cascinbelli N, Edwaurds MJ. Excision of primary melanoma. In: Balch C, Houghton A, Sober A, Soong S (eds) Cutanous melanoma, 4th edn. Quality Medical Publishing, St. Louis, 2003, pp. 209–230

    Google Scholar 

  • Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–983

    PubMed  CAS  Google Scholar 

  • Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. J Am Med Assoc 1998;280:1410–1415

    Article  CAS  Google Scholar 

  • McMasters KM. The sunbelt melanoma trial. Ann Surg Oncol 2001;8 (9 Suppl):41S–43S

    Google Scholar 

  • Shivers SC, Li W, Lin J, Stall A, Stafford M, Messina J, Glass LF, Reintgen DS. The clinical relevance of molecular staging for melanoma. Recent Results Cancer Res 2001;158:187–199

    PubMed  CAS  Google Scholar 

  • Reintgen D, Pendas S, Jakub J, Swor G, Giuliano R, Bauer J, Cassall R, Duhaime L, Alsarrai M, Shivers S. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol 2004;31:363–373

    Article  PubMed  Google Scholar 

  • Starz H, Balda BR, Kramer KU, Buchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110–2121

    Article  PubMed  CAS  Google Scholar 

  • Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M, Schlagenhauff B, Meier F, Schittek B, Blaheta HJ, Blum A, Rassner G. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003;21:520–529

    Article  PubMed  Google Scholar 

  • Puig S, Malvehy J, Badenas C, Ruiz A, Jimenez D, Cuellar F, Azon A, Gonzalez U, Castel T, Campoy A, Herrero J, Marti R, Brunet-Vidal J, Mila M. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005;23:3043–3051

    Article  PubMed  CAS  Google Scholar 

  • Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol 2002;20:297–304

    Article  PubMed  Google Scholar 

  • Tsao H, Feldman M, Fullerton JE, Sober AJ, Rosenthal D, Goggins W. Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival. Arch Dermatol 2004;140:67–70

    Article  PubMed  Google Scholar 

  • Wang TS, Johnson TM, Cascade PN, Redman BG, Sondak VK, Schwartz JL. Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. J Am Acad Dermatol 2004;51:399–405

    Article  PubMed  Google Scholar 

  • Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7–17

    PubMed  CAS  Google Scholar 

  • Kirkwood JM, Manola J, Ibrahim J, Sondak V, Ernstoff MS, Rao U, Eastern Cooperative Oncology Group. A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res 2004;10:1670–1677

    Article  PubMed  CAS  Google Scholar 

  • Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, Smith TJ, Rao U, Steele M, Blum RH. High- and low-dose interferon alpha-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000;18:2444–2458

    PubMed  CAS  Google Scholar 

  • Kilbridge KL, Cole BF, Kirkwood JM, Haluska FG, Atkins MA, Ruckdeschel JC, Sock DE, Nease RF Jr, Weeks JC. Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for highrisk melanoma patients using intergroup clinical trial data. J Clin Oncol 2002;20:1311–1318

    Article  PubMed  CAS  Google Scholar 

  • Eggermont AM, Suciu S, MacKie R, Ruka W, Testori A, Kruit W, Punt CJ, Delauney M, Sales F, Groenewegen G, Ruiter DJ, Jagiello I, Stoitchkov K, Keilholz U, Lienard D. EORTC Melanoma Group. Post-surgery adjuvant therapy with intermediate doses of interferon alpha 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial. Lancet 2005; 366:1189–1196

    Article  PubMed  CAS  Google Scholar 

  • Eggermont AM. Current status of interferon-alpha in the treatment of melanoma. Cancer Chemother Biol Response Modif 2005;22:729–737 99. Eggermont AM, Punt CJ. Does adjuvant systemic therapy with interferon-alpha for stage II–III melanoma prolong survival? Am J Clin Dermatol 2003;4:531–536

    Article  PubMed  Google Scholar 

  • Eggermont AM. Critical appraisal of IFN-alpha-based adjuvant therapy in stage II-III malignant melanoma. Expert Rev Anticancer Ther 2002;2:563–569

    Article  PubMed  CAS  Google Scholar 

  • Lens MB, Dawes M. Interferon alpha therapy for malignant melanoma: a systematic review of randomized controlled trials. J Clin Oncol 2002;20:1818–1825

    Article  PubMed  CAS  Google Scholar 

  • Cascinelli N, Belli F, MacKie RM, Santinami M, Bufalino R, Morabito A. Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial. Lancet 200115;358:866–869

    Google Scholar 

  • Grob JJ, Dreno B, Salmoniere P de la, Delaunay M, Cupissol D, Guillot B, Souteyrand P, Sassolas B, Cesarini JP, Lionnet S, Lok C, Chastang C, Bonerandi JJ. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma. Lancet 1998;351(9120):1905–1910

    Article  PubMed  CAS  Google Scholar 

  • Pehamberger H, Soyer HP, Steiner A, Kofler R, Binder M, Mischer P, Pachinger W, Aubock J, Fritsch P, Kerl H, Wolff K. Adjuvant interferon alpha-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol 1998;16:1425–1429

    PubMed  CAS  Google Scholar 

  • Morton DL, Essner R, Balch C. Surgical excision of distant metastasis. In: Balch C, Houghton A, Sober A, Soong S (eds) Cutanous melanoma, 4th edn. Quality Medical Publishing, St. Louis, 2003, pp. 547–572

    Google Scholar 

  • Atkins MB, Buzaid AC, Houghton AN Jr. Chemotherapy and biochemotherapy. In: Balch C, Houghton A, Sober A, Soong S (eds) Cutanous melanoma, 4th edn. Quality Medical Publishing, St. Louis, 2003, pp 589–604

    Google Scholar 

  • Atkins MB, Lotze MT, Dutcher, et al. High-dose recombinant interleukin-2 therapy for patients with metastasic melanoma; analyses of 270 patients treated between 1985 and 1993. J Clin Oncol 1999;17:2105–2116

    PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. The Queensland Institute of Dermatology, University of Queensland, QLD 4102, Brisbane, Australia

    Hans Peter Soyer

  2. Department of Dermatology, Second University of Naples, Via Pansini 5, I-80131, Naples, Italy

    Guiseppe Argenziano

  3. Department of Dermatology, Medical University Graz, Auenbruggerplatz 8, A-8036, Graz, Austria

    Rainer Hofmann-Wellenhof

  4. Pigmented Lesion Clinic, University of Miami, School of Medicine, 33136, Miami, FL, USA

    Robert H. Johr

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2007). Melanoma of the Trunk and Limbs Including Superficial and Nodular Melanoma. In: Soyer, H., Argenziano, G., Hofmann-Wellenhof, R., Johr, R. (eds) Color Atlas of Melanocytic Lesions of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35106-1_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-35106-1_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-35105-4

  • Online ISBN: 978-3-540-35106-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation